GREYSTONE MEDICAL GROUP INC has a total of 41 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and machines are ABRAHMSOHN GLENN, PG TXL CO LP and EUPHARMA PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Canada | 5 | |
#6 | China | 2 | |
#7 | Mexico | 2 | |
#8 | New Zealand | 2 | |
#9 | Cyprus | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Monroe Stephen H | 17 |
#2 | Hoekstra Hans | 13 |
#3 | Monroe Stephen | 8 |
#4 | Stanley R Thomas | 6 |
#5 | Hoekstra Matthias Johannes | 5 |
#6 | Jansen J A | 5 |
#7 | Van Den Berg A J J | 5 |
#8 | Hon David N S | 4 |
#9 | Moore Robert M | 4 |
#10 | Vooys D P P | 3 |
Publication | Filing date | Title |
---|---|---|
WO2006002326A2 | Methods for treatment of wounds using time release compositions | |
EP1660012A2 | Cellular depolarization and regulation of matrix metalloproteinases | |
WO2005002528A2 | Method for treating diabetes | |
US2004170703A1 | Reduction of reactive oxygen species in chronic wound management | |
CA2511440A1 | Reduction of reactive oxygen species in chronic wound management | |
US2004105897A1 | Composition and method for the therapeutic modulation of matrix metalloproteinase | |
CA2486704A1 | Anti-cancer formulation | |
AU2002359529A1 | Treatment of wounds and compositions employed | |
US7014870B1 | Compositions of oak bark extract related synthetic compositions and method of using same | |
NZ258019A | Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract |